Anti-D Injection

An Anti-D injection provides temporary protection for a Rhesus-negative pregnant person when fetal blood exposure could cause sensitisation. Anti-D immunoglobulin is made from donated human plasma and helps remove Rhesus-D-positive cells before the immune system reacts. It is offered after blood-group testing and according to pregnancy events and local maternity guidance.

A blood test identifies your ABO and Rhesus status and checks whether antibodies are already present. If you are Rhesus D negative without relevant antibodies, the team discusses routine antenatal Anti-D and additional doses after bleeding, abdominal injury, invasive testing, miscarriage, or birth when indicated. The injection is given into a muscle, with documentation of the date and reason.

Anti-D is used to reduce the chance of your immune system making antibodies that could affect a later Rhesus-positive pregnancy. Tell the clinician about allergies, previous reactions, immune conditions, and medicines. The injection does not treat established sensitisation, so blood-test results guide the plan. Ask for urgent advice after bleeding or injury during pregnancy.

You can ask whether your blood group and antibody screen are complete, why a dose is recommended, when it should be given, and what follow-up is needed. If you decline or delay, discuss how sensitisation risk will be assessed and monitored. Treatment choices depend on your antibody status, the pregnancy event, and whether the baby's Rhesus type is known.

Anti-D is prevention, not a vaccine that creates lasting immunity. It cannot remove antibodies that have already formed. Keep your blood-group result and injection record available, and tell every maternity professional about bleeding, procedures, or abdominal trauma.

It is generally considered for pregnant people who are Rhesus D negative and have not already formed the relevant antibodies. The need can arise during pregnancy, after a sensitising event, or after birth if the baby is Rhesus D positive. [Rhesus Incompatibility](/conditions/rhesus-incompatibility/) explains why blood-group differences matter.

The clinician checks your identity, blood results, allergies, the reason for treatment, and the product details. The dose is injected into a muscle, commonly the upper arm or another suitable site. You may be observed briefly and given a record of the injection. If a sensitising event has occurred, contact the maternity service promptly because timing can affect the plan.

You can usually continue ordinary activities. Mild soreness at the injection site, headache, or feeling generally unwell may occur for a short time. Follow the service's advice about observation and further blood tests. Report breathing difficulty, facial swelling, fainting, or a severe reaction urgently.

Most reactions are mild and occur around the injection site or briefly affect how you feel. A severe allergic reaction is possible and needs immediate treatment. Anti-D does not protect against every blood-group antibody and cannot reverse sensitisation that is already established.

Some services can use additional fetal or newborn blood-group information to guide whether post-birth Anti-D is needed. If antibodies are present, care usually shifts to specialist blood tests and fetal monitoring rather than routine prevention. Your maternity team will explain which pathway fits your results.

Contact a maternity service with access to blood-group testing, antibody review, and documented follow-up. Ask how to report bleeding, injury, or a procedure outside normal clinic hours. Bring previous blood results and your injection record to every pregnancy appointment.